Navigation Links
Ohr Pharmaceutical Announces Approval for Listing on NASDAQ
Date:6/12/2013

NEW YORK, June 12, 2013 /PRNewswire/ -- Ohr Pharmaceutical, Inc. (OTCQB: OHRPD), a pharmaceutical company focused on the development of novel therapeutics for large unmet medical needs, today announced that it has received confirmation that its application to list the company's common stock on the NASDAQ Capital Market has been approved by The NASDAQ Stock Market, a unit of the NASDAQ OMX Group. In honor of the listing, the Company will ring the Opening Bell at the NASDAQ MarketSite in Times Square, New York City, on Thursday, June 13 (Link to the live webcast beginning at 9:20am ET).

Ohr's common stock is expected to begin trading on the NASDAQ Capital Market at the opening of trading on June 13, 2013 under the ticker symbol, OHRP. The Company's common stock will continue to trade on the Over-the-Counter Bulletin Board until the market close on June 12, 2013 under the ticker symbol, OHRPD.

"Our listing on the NASDAQ Capital Market is a major corporate milestone for our Company and a testament to the tremendous progress we have made over the past few years," stated Dr. Irach Taraporewala, CEO of Ohr Pharmaceutical. "We believe that the listing on NASDAQ will help broaden our shareholder base, increase appeal to institutional investors, provide us with better liquidity and ultimately contribute to increasing shareholder value. We continue to execute on our clinical and corporate strategy, and anticipate achieving 50% enrollment of the Squalamine Eye Drop phase II wet-AMD trial in the near term, as per our previous guidance."

About Ohr Pharmaceutical, Inc.
Ohr Pharmaceutical, Inc. (OTCQB: OHRPD) is a pharmaceutical company dedicated to the clinical development of new drugs for underserved therapeutic needs in large and growing markets. The Company is focused o
'/>"/>

SOURCE Ohr Pharmaceutical, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. GDS International Leads the Way for the Pharmaceutical Industry at its Upcoming NGP DD 30 Summit in Madrid
2. Pointlogic and Kantar Media Announce Dedicated Communication Planning Solution for Pharmaceutical Industry
3. The Top Five Global Pharmaceutical Companies: Performance, Strategies and Competitive Analysis
4. Breckenridge Pharmaceutical signs Letter of Intent with Welding GmbH & Co & SK Chemicals
5. Pharmapack North America - Event to Cover Drug Security, Track and Trace, Pharmaceutical Packaging Design and Patient Compliance
6. Adamas Pharmaceuticals To Report Positive Phase 2/3 Results For ADS-5102 For The Treatment Of Levodopa-Induced Dyskinesia In Parkinsons Disease
7. Access Pharmaceuticals Signs US License Agreement With AMAG Pharmaceuticals For MuGard
8. HemaQuest Pharmaceuticals Completes Patient Enrollment in Phase 2b Clinical Study of HQK-1001 in Patients with Sickle Cell Disease
9. Oramed Pharmaceuticals to Present at IATI-BioMed Conference in Israel
10. DelMar Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
11. Valeant Pharmaceuticals Announces Filing Of Preliminary Base Shelf Prospectus
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... DIEGO, July 29, 2015 Neurocrine Biosciences, Inc. (NASDAQ: ... June 30, 2015. For the second quarter of 2015, the Company ... share, compared to a net loss of $13.4 million, or $0.18 ... six months ended June 30, 2015, the Company reported a net ... to net loss of $25.2 million, or $0.35 loss per share, ...
(Date:7/29/2015)... , July 29, 2015 Immune Pharmaceuticals Inc. ... secured financings of up to $21.5 million through two ... Inc. (NYSE: HTGC ) ("Hercules"), for a term loan ... mutual fund Discover Growth Fund ("Discover"), for the sale ... Preferred Stock ("Preferred Stock") for up to $12 million ...
(Date:7/29/2015)... DALLAS , July 29, 2015 ... Apnea Devices Market by Product, Diagnostic (PSG, Pulse Oximeter), ... Appliances (Mandibular Advancement Device)], End User (Home Care Settings, ... by MarketsandMarkets, this report studies the global Sleep Apnea ... 2020. This market is expected to reach $5.3 Billion ...
Breaking Medicine Technology:Neurocrine Biosciences Reports Second Quarter 2015 Results 2Neurocrine Biosciences Reports Second Quarter 2015 Results 3Neurocrine Biosciences Reports Second Quarter 2015 Results 4Neurocrine Biosciences Reports Second Quarter 2015 Results 5Neurocrine Biosciences Reports Second Quarter 2015 Results 6Neurocrine Biosciences Reports Second Quarter 2015 Results 7Neurocrine Biosciences Reports Second Quarter 2015 Results 8Neurocrine Biosciences Reports Second Quarter 2015 Results 9Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 2Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 3Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 4Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 5Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 6Immune Pharmaceuticals secures funding of up to $21.5 Million from institutional Investors 7Sleep Apnea Devices Market Worth $5.3 Billion by 2020 2Sleep Apnea Devices Market Worth $5.3 Billion by 2020 3Sleep Apnea Devices Market Worth $5.3 Billion by 2020 4
... Phase I data from XL880, Phase II data from ... SOUTH SAN FRANCISCO, May 30, 2007 /PRNewswire-FirstCall/ --,Exelixis, Inc. ... investigational compounds XL880 and XL999 will be,presented at the ... is being held June 1 to 5 in Chicago,Illinois. ...
... many as,first-line in secondary stroke prevention , ... presented today at the,16th European Stroke Conference in ... dipyridamole plus ASA,is marketed as Aggrenox® or Asasantin® ... vascular events in patients who had,a TIA or ...
Cached Medicine Technology:Six Abstracts Featuring Exelixis Compounds Accepted At ASCO,Conference 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 2New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 3New Research Confirms the Benefit of Extended-Release Dipyridamole,Plus ASA for Preventing Recurrent Stroke in Low- and High-Risk,Patients 4
(Date:7/30/2015)... CA (PRWEB) , ... July 30, 2015 , ... At the presentation of the 2015 ... discussion was focused on research presented by the Journal of Arthroplasty pertaining to ... – like driving. , Results of the study confirm what Santa Rosa Orthopaedics ...
(Date:7/30/2015)... ... 30, 2015 , ... World Breast-Feeding Week (Aug. 1-7) was ... have the nutrition required to grow into healthy adults. Medicationdiscountcard.com supports ... prescription pre-natal vitamins. , Folic Acid , Arguably one of the most important ...
(Date:7/29/2015)... Plano, TX (PRWEB) , ... July 30, 2015 ... ... best content available for their clients, BOC approved provider of online continuing ... six new course offerings to their exclusive Andrews Research and Education Sports Medicine ...
(Date:7/29/2015)... ... July 29, 2015 , ... Avatar Solutions has received official approval from ... Survey. , The CAHPS for PQRS Survey collects information about patients’ experiences ... eligible providers must participate or they will receive a 2% penalty in 2017. At ...
(Date:7/29/2015)... ... July 29, 2015 , ... This past week, ... surrogacy journey from a treasured member of the CARE extended family. , By ... to help intended parents across the globe gain a newfound perspective on surrogacy in ...
Breaking Medicine News(10 mins):Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 2Health News:SRO Surgeon Dr. Nathan Ehmer Backs Up Latest Study That Total Hip Replacement Surgery Patients Are Resuming Normal Activities Sooner 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 2Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 3Health News:Medicationdiscountcard.com Encourages Pre-Natal Wellness in Time for World Breast-Feeding Week 4Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 2Health News:Elite Online Continuing Education Provider Adds Six New Athletic Training Courses to Exclusive Andrews Research and Education Sports Medicine Series 3Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 2Health News:Avatar Solutions Approved to Administer CAHPS for Physician Quality Reporting System (PQRS) 3Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 2Health News:Heartfelt Interview Shows Extraordinary Impact of CARE Surrogacy Center Mexico 3
... Black Americans with lupus have a higher antibody response to ... This may be good news for black Americans with ... the flu vaccine were more likely to experience moderate to ... a greater response. As many as 322,000 adults in ...
... prevents and cures kidney failure in mice sheds light ... potential treatment in people with such illnesses. ... in animals," said study leader Marni J. Falk, M.D., ... at The Children,s Hospital of Philadelphia. "So these striking ...
... sperm quality and who are trying to have children should ... cell phone use appears to increase the level of testosterone ... sperm quality and a decrease in fertility. "Our ... postdoctoral fellow in the Department of Pharmacology and Toxicology and ...
... 19, 2011) The John Theurer Cancer Center at Hackensack ... Promise Foundation to host a skin cancer screening event on ... feature educational information on skin cancer prevention and offer free ... "Skin cancer can be a devastating disease, but ...
... Autnoma de Barcelona researchers have discovered that Viagra drastically ... disease. The research, published in Acta Neuropathologica , ... of the animals after eight days of treatment. Researchers ... out in patients given that the drug is well ...
... Today 16 countries announced new commitments to dramatically reduce ... Global Strategy for Women,s and Children,s Health. ... children,s health is reaching new and encouraging heights. The ... prove that saving the lives of the most vulnerable ...
Cached Medicine News:Health News:Black Americans With Lupus Have Better Response to Flu Vaccine 2Health News:Animal results may pave way to treating rare mitochondrial diseases in children 2Health News:Viagra could reduce multiple sclerosis symptoms 2Health News:New commitments to save women and children 2Health News:New commitments to save women and children 3Health News:New commitments to save women and children 4Health News:New commitments to save women and children 5Health News:New commitments to save women and children 6Health News:New commitments to save women and children 7Health News:New commitments to save women and children 8